The Journal of Nutritional Biochemistry
Volume 20, Issue 12 , Pages 965-973 , December 2009

The protective effect of dietary eicosapentaenoic acid against impairment of spatial cognition learning ability in rats infused with amyloid β(1–40)

  • Michio Hashimoto

      Affiliations

    • Department of Environmental Physiology, Shimane University Faculty of Medicine, Izumo, Shimane 693-8501, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 853 20 2110; fax: +81 853 20 2110.
  • ,
  • Shahdat Hossain

      Affiliations

    • Department of Environmental Physiology, Shimane University Faculty of Medicine, Izumo, Shimane 693-8501, Japan
  • ,
  • Yoko Tanabe

      Affiliations

    • Department of Environmental Physiology, Shimane University Faculty of Medicine, Izumo, Shimane 693-8501, Japan
  • ,
  • Akiko Kawashima

      Affiliations

    • Developmental Research, Pharmaceutical Research Center, Mochida Pharmaceutical Co., Ltd., Gotemba, Shizuoka 412-8524, Japan
  • ,
  • Tsuyoshi Harada

      Affiliations

    • Developmental Research, Pharmaceutical Research Center, Mochida Pharmaceutical Co., Ltd., Gotemba, Shizuoka 412-8524, Japan
  • ,
  • Takashi Yano

      Affiliations

    • Developmental Research, Pharmaceutical Research Center, Mochida Pharmaceutical Co., Ltd., Gotemba, Shizuoka 412-8524, Japan
  • ,
  • Kiyoshi Mizuguchi

      Affiliations

    • Developmental Research, Pharmaceutical Research Center, Mochida Pharmaceutical Co., Ltd., Gotemba, Shizuoka 412-8524, Japan
  • ,
  • Osamu Shido

      Affiliations

    • Department of Environmental Physiology, Shimane University Faculty of Medicine, Izumo, Shimane 693-8501, Japan

Received 22 March 2008 ,Revised 20 August 2008 ,Accepted 25 August 2008.

References 

  1. Hamano H, Nabekura J, Nishikawa M, Ogawa T. Docosahexaenoic acid reduces GABA response in substantia nigra neuron of rat. J Neurophysiology. 1996;75:1264–1270
  2. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297:353–356
  3. Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol. 1997;42:776–782
  4. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol. 2003;60::940–946
  5. Gamoh S, Hashimoto M, Sugioka K, Shahdat Hossain M, Hata N, Misawa Y, et al. Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats. Neuroscience. 1999;93:237–241
  6. Gamoh S, Hashimoto M, Hossain S, Masumura S. Chronic administration of docosahexaenoic cid improves the performance of radial arm maze task in aged rats. Clin Exp Pharmacol Physiol. 2001;28:266–270
  7. Hashimoto M, Hossain S, Shimada T, Sugioka K, Yamasaki H, Fujii Y, et al. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J Neurochem. 2002;81:1084–1091
  8. Hashimoto M, Tanabe Y, Fujii Y, Kikuta T, Shibata H, Shido O. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. J Nutr. 2005;135:549–555
  9. Calon F, Lim GP, Yang F, et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron. 2004;43:633–635
  10. Song C, Horrobin D. Omega-3 fatty acid ethyl-eicosapentaenoate, but not soybean oil, attenuates memory impairment induced by central IL-1beta administration. J Lipid Res. 2004;45:1112–1121
  11. Kitajka K, Puskas LG, Zvara A, Hackler L, Barcelo-Coblijn G, Yeo YK, et al. The role of n-3 polyunsaturated fatty acids in brain: modulation of rat brain gene expression by dietary n-3 fatty acids. Proc Natl Acad Sci U S A. 2002;99:2619–2624
  12. Lauritzen L, Hansen HS, Jorgensen MH, Michaelson KF. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res. 2001;40:1–94
  13. Ishiguro J, Tada T, Ogihara T, Murakami K, Kunihiro Y. Studies on the metabolic disposition of ethyl eicosapentaenoate (EPA-E) in rats and dogs. Drug Metabol Dispos. 1987;2:683–702
  14. Moore SA. Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro. J Mol Neurosci. 2001;16:195–200[discussion 215–1]
  15. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–358
  16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin reagent. J Biol Chem. 1951;193:265–275
  17. Lockhart DJ, Dong H, Byrne MC, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol. 1996;14:1675–1680
  18. Hashimoto M, Shinozuka K, Hossain MS, Kwon YM, Tanabe Y, Kunitomo M, et al. Antihypertensive effect of all-cis-5,8,11,14,17-icosapentaenoate of aged rats is associated with an increase in the release of ATP from the caudal artery. J Vasc Res. 1998;35:55–62
  19. Hashimoto M, Shinozuka K, Gamoh S, et al. The hypotensive effect of docosahexaenoic acid is associated with the enhanced release of ATP from the caudal artery of aged rats. J Nutr. 1999;129:70–76
  20. Spector AA. Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty acid for the brain. J Mol Neurosci. 2001;16:159–165[discussion 215–1]
  21. Salem N. Omega-3 fatty acids: molecular and biochemical aspects. In:  Spiller GA,  Scala J editor. New protective roles for selected nutrients. New York: Alan R. Liss; 1989;p. 109–228
  22. Salem N, Moriguchi T, Greiner RS, McBride K, Ahmad A, Catalan JN, et al. Alterations in brain function after loss of docosahexaenoate due to dietary restriction of n-3 fatty acids. J Mol Neurosci. 2001;16:299–307
  23. Behl C, Moosmann B. Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach. Free Radic Biol Med. 2002;33:182–191
  24. Hossain MS, Hashimoto M, Gamoh S, Masumura S. Antioxidative effects of docosahexaenoic acid in the cerebrum versus cerebellum and brainstem of aged hypercholesterolemic rats. Neurochem. 1999;72:1133–1138
  25. Hashimoto M, Hossain S, Agdul H, Shido O. Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid beta-infused rats relates to the decreases of amyloid beta and cholesterol levels in detergent-insoluble membrane fractions. Biochim Biophys Acta. 2005;1738:91–98
  26. Lim S, Suzuki H. Changes in maze behavior of mice occur after sufficient accumulation of docosahexaenoic acid in brain. J Nutr. 2001;131:319–324
  27. Tanabe Y, Hashimoto M, Sugioka K, Maruyama M, Fujii Y, Hagiwara R, et al. Improvement of spatial cognition with dietary docosahexaenoic acid is associated with an increase in Fos expression in rat CA1 hippocampus. Clin Exp Pharmacol Physiol. 2004;l31:700–703
  28. Hirono M, Yoshioka T, Konishi S. GABA(B) receptor activation enhances mGluR-mediated responses at cerebellar excitatory synapses. Neuroscience. 2001;12:1207–1216
  29. Fujiwara T, Yamamori T, Akagawa K. Suppression of transmitter release by Tat HPC-1/syntaxin 1A fusion protein. Biochim Biophys Acta. 2001;1539:225–232
  30. Sung U, Apparsundaram S, Galli A, Kahlig KM, Savchenko V, Schroeter S, et al. A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity. J Neurosci. 2003;23:1697–1699
  31. Abrahamson M, Barrett AJ, Salvesen G, Grubb A. Isolation of six cysteine proteinase inhibitors from human urine. J Biol Chem. 1986;261:11282–11289
  32. Cataldo AM, Barnett JL, Pieroni C, Nixon RA. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased β-amyloidogenesis. J Neurosci. 1997;17:6142–6151
  33. Taupin P, Ray J, Fischer VM, Suhr ST, Hakansson K, Grubb A, et al. FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. Neuron. 2000;28:385–387
  34. Kawakita E, Hashimoto M, Shido O. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience. 2006;139:991–997
  35. Chen YG, Siddhanta A, Austin CD, Hammond SM, Sung TC, Frohman MA, et al. Phospholipase D stimulates release of nascent secretory vesicles from the trans-Golgi network. Cell Biol. 1997;138:495–504
  36. Humeau Y, Vitale N, Chasserot-Golaz S, Dupont JL, Du G, Frohman MA, et al. A role for phospholipase D1 in neurotransmitter release. Proc Natl Acad Sci U S A. 2001;98:15300–15305
  37. Cai D, Zhong M, Wang R, Netzer WJ, Shields D, Zheng H, et al. Phospholipase D1 corrects impaired beta APP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons. Proc Natl Acad Sci U S A. 2006;103:1936–1940
  38. Hirabayashi M, Inoue K, Tanaka K, Nakadate K, Ohsawa Y, Kamei Y, et al. VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ. 2001;8:977–984
  39. Shahdat H, Hashimoto M, Shimada T, Shido O. Synaptic plasma membrane-bound acetylcholinesterase activity is not affected by docosahexaenoic acid-induced decrease in membrane order. Life Sci. 2004;74:3009–3024
  40. Hashimoto M, Hossain S, Shimada T, Shido O. Docosahexaenoic acid-induced protective effect against impaired learning in amyloid beta-infused rats is associated with increased synaptosomal membrane fluidity. Clin Exp Pharmacol Physiol. 2006;33:934–939
  41. Clarke MS, Prendergast MA, Terry AV. Plasma membrane ordering agent pluronic F-68 (PF-68) reduces neurotransmitter uptake and release and produces learning and memory deficits in rats. Learn Mem. 1999;6:634–639
  42. Minami M, Kimura S, Endo T, Hamaue N, Hirafuji M, Togashi H, et al. Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats. Pharmacol Biochem Behavior. 1997;58:1123–1129
  43. Puskàs LG, Kitajka K, Nyakas C, Barcelo-Coblijn G, Farkas T. Short-term administration of omega 3 fatty acids from fish oil results in increased transthyretin transcription in old rat hippocampus. Proc Natl Acad Sci U S A. 2003;100:1580–1585
  44. Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O, et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci. 2005;25:3032–3040
  45. Sousa JC, Cardoso I, Marques F, Saraiva MJ, Palha JA. Transthyretin and Alzheimer's disease: where in the brain?. Neurobiol Aging. 2007;28:713–718
  46. Anderson KL, Ferreira A. Integrin activation. A link between β-amyloid deposition and neuronal death in aging hippocampal neurons. J Neurosci Res. 2004;75:688–697

PII: S0955-2863(08)00200-3

doi: 10.1016/j.jnutbio.2008.08.009

The Journal of Nutritional Biochemistry
Volume 20, Issue 12 , Pages 965-973 , December 2009